2.7. Cell Viability Assay (MTT)

ES Ekaterina V. Starostina
SS Sergei V. Sharabrin
DA Denis N. Antropov
GS Grigory A. Stepanov
GS Georgiy Yu. Shevelev
AL Anna E. Lemza
AR Andrey P. Rudometov
MB Mariya B. Borgoyakova
NR Nadezhda B. Rudometova
VM Vasiliy Yu. Marchenko
ND Natalia V. Danilchenko
AC Anton N. Chikaev
SB Sergei I. Bazhan
AI Alexander A. Ilyichev
LK Larisa I. Karpenko
ask Ask a question
Favorite

The cytotoxicity of mRNA modifications was assessed using the MTT test [26]. HEK293FT, PC3, and A549 cells (1 × 105 cells/mL) in 100 μL cell culture were seeded in 96-well plates and incubated by night. The next day, mRNA-M0, mRNA-M2, mRNA-M6, and mRNA-M7 were added to the cells at a concentration in the range from 50 μg/mL to 0.4 μg/mL and incubated for 72 h. After 72 h of cell incubation with the tested complexes, 20 μL of the MTT solution (5 mg/mL) was added to each well and incubated for 2 h in a CO2-incubator. After incubation, we removed the medium and added dimethyl sulfoxide (50 μL/well) to terminate the reaction. Optical density was detected via a microplate reader Varioskan LUX (Thermo Fisher Scientific, Waltham, MA, USA) at a wavelength of 570 nm. Cell viability in the presence of complexes was calculated as follows: [(optical density of texted wells/optical density of control wells) × 100%].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A